Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?

Min ZhangDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, ChinaYifan ZhaoDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, ChinaHe MaInstitute of Biomedical Materials and Engineering, College of Materials Sciences and Engineering, Qingdao University, Qingdao 266071, ChinaYusong SunDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, ChinaJie CaoDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, China
2022en
ABI

Аннотация

Photodynamic therapy (PDT) is a promising method of tumor ablation and function-preserving oncological intervention, which is minimally invasive, repeatable, and has excellent function and cosmetic effect, with no cumulative toxicity. More importantly, PDT can induce immunogenic cell death and local inflammation, thus stimulating the body's immune response. However, the weak immunity induced by PDT alone is insufficient to trigger a systemic immune response towards cancer cells. To overcome this obstacle, multiple strategies have been investigated, including tumor microenvironment remodeling, tumor vaccines, subcellular-targeted PDT, and synergistic therapies. This review summarizes the latest progress in the development of strategies to improve the PDT-induced immune effect for enhanced cancer treatment.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0